What should a nurse expect a provider to do when a pregnant client on ACE inhibitors contacts them regarding her medication?

In the context of a pregnant client taking ACE inhibitors, the correct course of action is to discontinue the drug. ACE inhibitors are known to have potentially harmful effects on the fetus, particularly when used during the second and third trimesters. These medications can lead to complications such as fetal renal problems, low amniotic fluid levels (oligohydramnios), and, in severe cases, fetal death. The risks associated with continuing ACE inhibitors during pregnancy outweigh any potential benefits.

Therefore, when a pregnant client indicates a concern regarding her medication, the provider's priority would typically be to stop the use of ACE inhibitors and consider alternative treatments for managing high blood pressure that are safer during pregnancy, such as methyldopa, labetalol, or nifedipine.